Torbay Pharma
Daniel Clemence is an experienced professional currently serving as an Audit and Supply Officer at Torbay Pharmaceuticals, focusing on regulatory compliance, quality assurance, and supplier auditing. Daniel also acts as a Seed Investor at Crowdcube, having invested in over 50 ventures across various sectors, including food and drink, engineering, and tech start-ups. Previous roles include English Language Consultant, Freelance Journalist specializing in political analysis, Care Support Worker, and Consultancy Team Leader for a feasibility study on domiciliary care. Daniel holds a Bachelor's degree in Philosophy and Politics from the University of Southampton.
Torbay Pharma
Torbay Pharma is a licence holder and global specialist in the manufacture and supply of terminally sterilized injectables for the secondary care market. We work with generic pharmaceutical companies seeking to ensure their sterile injectable products get to market reliably and without delay. As a CMO and CDMO, we offer fill/finish services for terminally sterilised injectables into plastic and glass vials and ampoules. Our specialist portfolio includes licensed and unlicensed terminally sterilised injectables, electrolyte solutions for total parenteral nutrition (TPN) compounding and a range of non-sterile oral solutions. Established in the 1970s as part of the Torbay and Devon NHS Foundation Trust, we have grown into a 250-strong team operating from our purpose built manufacturing facility in Paignton, UK. November 2023 saw us receive investment from NorthEdge, we’re now Torbay Pharmaceuticals Ltd. Torbay Pharma offer niche product experience and capabilities, an agile approach and a team of experts who genuinely care. Our determination and flexibility at every step, ensure quality products are efficiently supplied to market, with clear communication and consultancy throughout the process. If you think we can help you with your next project, visit our website: www.torbaypharma.com